talis.bio (TLIS): Prakiraan volume dodolan

Talis Biomedical (TLIS) attracts leading engineers with innovations in rapid testing, although the ecosystem is currently undergoing restructuring due to FDA challenges and customer churn. The development of portable AI systems for molecular infection analysis minimizes personnel errors. The firm's projected sales volume visualizes demand dynamics, and the value of 0.00 captures this metric on the chart.

TLIS - Prakiraan pendapatan perusahaan Talis Biomedical ing rentang 04.07.2022 - 07.09.2024

Rincian metrik lan analitis perusahaan Talis Biomedical Corp (TLIS)

- nilai saham lan prakiraan konsensus rega:

Bagan rega Talis Biomedical|TLIS - Target konsensus

- data kapitalisasi bursa:

Kapitalisasi pasar Talis Biomedical Corp.|TLIS - Total Nilai Perusahaan

- informasi kapitalisasi buku:

Nilai Buku saben Saham Talis Biomedical|TLIS - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku talis.bio|TLIS - Gunggung Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Total Utang marang Modal Talis Biomedical|TLIS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Talis Biomedical|TLIS - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Talis Biomedical Corp.|TLIS - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Talis Biomedical|Rasio cepet talis.bio

- statistik bathi lan rasio pasar:

TLIS - Penghasilan resik perusahaan|Bathi sing dikarepake Talis Biomedical|TLIS - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Talis Biomedical|TLIS - Pangali PEG|Pangali EV/EBITDA Talis Biomedical Corp.|TLIS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Talis Biomedical|TLIS - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan talis.bio|TLIS - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Talis Biomedical

- indikator pendapatan dodolan lan penghasilan bisnis:

TLIS - Total pendapatan perusahaan|Prakiraan pendapatan perusahaan Talis Biomedical|TLIS - Rasio kapitalisasi marang pendapatan|Multiplikator forward rega marang pendapatan Talis Biomedical Corp.

Analisis komprehensif perusahaan:TLIS Talis Biomedical Corporation

Investing in Talis Biomedical (TLIS) requires a rigorous analysis of the business's ability to maintain financial stability. This indicator measures the fundamental margin of safety by assessing revenue generation potential amid market volatility. By analyzing the organization's future sales revenue, an investor determines the risk of capital drawdowns. For Talis Biomedical (TLIS), this metric reflects the efficiency of deploying diagnostic systems through clinic partnerships. A stable trend confirms the high quality of the issuer's capital.

Perusahaan pesaing